Akebia's Vadadustat Misses In Non-Dialysis CKD, But Filings Still Planned For 2021

Kidney Disease - Printed Diagnosis with Red Pills, Injections and Syringe. Medical Concept with Selective Focus.
Akebia hoped vadadustat would show a safety benefit in non-dialysis CDK versus ESAs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Genitourinary

More from Therapeutic Category